Pfizer reports fall at home but rise abroad

3 May 2017 - Deborah Wilkes

Archived

Pfizer Consumer Healthcare's sales in the first quarter of 2017 fell by 2% in the US but rose by 10% in international markets on an operational basis.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: